Camber launches generic Cambia
The medication is a non-steroidal anti-inflammatory drug indicated for the acute treatment of migraine attacks with or without aura, in adults 18 years of age or older.
Camber is introducing diclofenac potassium for oral solution, a generic of Cambia.
The medication is a non-steroidal anti-inflammatory drug indicated for the acute treatment of migraine attacks with or without aura, in adults aged 18 years old and older.
[Read more: Camber intros generic Trileptal]
Camber’s generic Cambia is available in a dosage strength of 50 mg and supplied as a box of 9 individual packets.